New Delhi: The World Health Organisation on Friday issued emergency use listing for anti-COVID vaccine Covovax produced by Serum Institute of India under licence from Novavax, expanding the basket of jabs validated by the global health body against the viral disease. Adar Poonawalla, the CEO of Serum Institute of India (SII), hailed WHO’s decision as “yet […]
